Department of Biochemistry Archive — Page 3 of 14
-
September 30, 2021
Molecular imaging of C. diff infection
C. difficile — the leading cause of hospital-associated intestinal infections — induces a rapid influx of bile acids into the gut, which could provide a novel target for blocking infection. -
September 2, 2021
Discovery offers insight for development of cancer therapies targeting mutant p53
Vanderbilt researchers have discovered that aneuploidy (an abnormal number of chromosomes) drives malignant phenotypes in cells expressing mutant p53, a tumor suppressor protein that is mutated in more than half of all human cancers. -
August 19, 2021
Expression atlas for cell regulators
Vanderbilt researchers report a comprehensive tissue-specific atlas of protein and mRNA expression for p63 and p73, members of the p53 family signaling network that is the most frequent target of mutations in human cancers. -
July 29, 2021
Cortez named chair of Department of Biochemistry
David Cortez, PhD, Richard N. Armstrong, PhD, Professor of Innovation in Biochemistry and professor of Biochemistry, has been appointed chair of the Department of Biochemistry. -
July 22, 2021
Researchers discover that protein switches functions to regulate DNA replication
Vanderbilt biochemists have discovered what the DNA damage response protein RADX does — and how it does it. -
April 15, 2021
Arrhythmia culprit: supertrafficking ion channel
Charles Sanders, PhD, and colleagues show how a “supertrafficking” mutant potassium channel contributes to heart rhythm abnormalities. -
February 4, 2021
Gene network for leukemia factor
A new method speeds the analysis of factors that control gene expression from days to minutes, allowing researchers to uncover new targets for cancer treatment.